Focus on Cancer

We retired this podcast, because we couldn't parse it for 10 consecutive times.

According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.

Website: http://reachmd.com/programs/focus-on-cancer/
Description: According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.
Language: 🇬🇧 English
last modified: 2023-05-12 19:08
last episode published: 2019-01-15 00:00
publication frequency: 18.35 days
Contributors: ReachMD; Author Owner
Explicit: false
Number of Episodes: 220
Rss-Feeds: Detail page
Categories: Medicine Science & Medicine Health & Fitness

0 Likes 0 Followers 1 Subscribers

Sign up / Log in to like, follow, recommend and subscribe!

Recommendations

Episodes

Date	Title & Description	Contributors
2019-01-15	An Overwhelming Outcome After a NSCLC Patient's Change in Care Host: Matt Birnholz, MD Guest: Christine Bestvina, MD Dr. Christine Bestvina, Assistant Professor of Medical Oncology at the University of Chicago, retells the case of one non-small cell lung cancer patient whose need for a change in treatment c...
2019-01-15	Tackling the Challenges of Care Coordination in NSCLC Host: Jennifer Caudle, DO Guest: Christine Bestvina, MD Family physician Dr. Jennifer Caudle and oncologist Dr. Christine Bestvina come together to take on the many questions surrounding care coordination in non-small cell lung cancer. Addressin...
2019-01-15	Latest Guidelines Bring Change for NSCLC Care Host: Matt Birnholz, MD Guest: Christine Bestvina, MD Highlighting the new guidelines brought forth by the National Comprehensive Cancer Network is Dr. Christine Bestvina, Assistant Professor of Medical Oncology from the University of Chicago. With...
2019-01-15	Latest Guidelines Bring Change for NSCLC Care Host: Matt Birnholz, MD Guest: Christine Bestvina, MD Highlighting the new guidelines brought forth by the National Comprehensive Cancer Network is Dr. Christine Bestvina, Assistant Professor of Medical Oncology from the University of Chicago. With...
2018-12-10	Revealing the Key Statistics of NSCLC Guest: Everett E. Vokes, MD Dr. Everett Vokes, Professor at the University of Chicago, brings to light the reality of one of the deadliest diseases in the United States and the glaring repercussions encountered. Closing the Gaps in NSCLC is sponso...
2018-12-10	Evolving Insights Into the Pathophysiology of NSCLC Guest: Everett E. Vokes, MD Over the years, we’ve seen insights and advances emerge in the field of NSCLC, leading to better physician understanding and patient management. But at the heart of all breakthroughs and innovations lies the foundation ...
2018-12-10	Facing False Positives in CT-Based NSCLC Screenings Host: Matt Birnholz, MD Guest: Everett E. Vokes, MD To address some of the difficulties surrounding CT-based NSCLC screenings, Dr. Everett Vokes provides guidance to thwart false positives. Closing the Gaps in NSCLC is sponsored by Lilly. Conten...
2018-12-10	Clinical Pearls for Challenging Cases of Advanced NSCLC Host: Matt Birnholz, MD Guest: Everett E. Vokes, MD With no one patient being the same, there’s a lot to consider when developing a treatment plan for advanced non-small cell lung cancer, and complex cases, such as elderly patients, can bring co...
2018-12-10	A Practical Perspective on Aggressive Disease Management in NSCLC Host: Matt Birnholz, MD Guest: Everett E. Vokes, MD Flipping the term “aggressive” on its head is Dr. Everett Vokes from the University of Chicago. Dr. Vokes unveils the term “intensive therapy” to describe his approach to aggressive NSCLC manag...
2018-12-01	The Expanding Value of Biomarkers in NSCLC Treatment Host: Shira Johnson, MD Guest: Ross Camidge, MD, PhD The treatment landscape for non-small cell lung cancer is continuing to expand, and playing a major role in clinical decision-making are biomarkers. Dr. Ross Camidge reveals the importance of ...